GSTC logo

GlobeStar Therapeutics Corporation Stock Price

OTCPK:GSTC Community·US$1.2k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

GSTC Share Price Performance

US$0.000001
-0.00 (-99.71%)
US$0.000001
-0.00 (-99.71%)
Price US$0.000001

GSTC Community Narratives

There are no narratives available yet.

Snowflake Analysis

Moderate risk with weak fundamentals.

5 Risks
0 Rewards

GlobeStar Therapeutics Corporation Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$919.3k

Other Expenses

-US$919.3k

Earnings

Last Reported Earnings
Jun 30, 2024
Next Reporting Earnings
n/a
-0.00074
0%
0%
-20.2%
View Full Analysis

About GSTC

Founded
n/a
Employees
n/a
CEO
James Katzaroff
WebsiteView website
www.globestartherapeutics.com

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.

Recent GSTC News & Updates

Recent updates

No updates